News

ascopubs.org4d
Survival analysis based on markers of progression in melanoma: A single-center comparison of survival in patients with high vs low biomarkers.
Gene set enrichment analysis of melanoma primary tumor transcriptome to identify pathways associated with lymph node metastasis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
ascopubs.org4d
Comparison of ctDNA and hematologic ratios as markers of disease progression in early versus late-stage melanoma: A single-center retrospective study.
Cardiovascular and oncologic outcomes of nivolumab + ipilimumab vs. pembrolizumab in malignant melanoma: A global real-world data analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...